Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-20-005777
Date:2020-08-31
Issuer: AMARIN CORP PLC\UK (AMRN)
Original Submission Date:

Reporting Person:

THERO JOHN F
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22 BRIDGEWATER, NJ 08807

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2020-08-31 M 6,736 a $0.00 2,528,025 direct
ORDINARY SHARES 2020-08-31 M 6,736 a $0.00 2,534,761 direct
ORDINARY SHARES 2020-08-31 F 5,302 d $7.36 2,529,459 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2020-08-31 deemed execution date M 6,736 (d) ordinary shares 6,736 $0.00 80,833 direct
RESTRICTED STOCK UNITS 0.0 2020-08-31 deemed execution date M 6,736 (d) ordinary shares 6,736 $0.00 80,833 direct
Footnotes
IDfootnote
f1 the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share.
f2 as previously reported on february 27, 2020, on may 15, 2017, the reporting person was granted 970,000 restricted stock units ("rsus") under the amarin corporation plc stock incentive plan (the "plan"), of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on february 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. the tranches vest ratably over 36 months beginning september 30, 2018 subject to achievement of the performance criteria and continued employment of the reporting person as provided in the rsu award agreement between the issuer and reporting person. the twenty-fourth vesting event occurred on august 31, 2020. the performance criteria related to the remaining 50% tranche has not yet been achieved; such tranche has not lapsed as a result of achieving the other two tranches.
f3 not applicable.
f4 represents withholding by the issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with rule 16b-3, and not a market sale of securities.
f5 please see the section titled "remarks" below for additional information.
f6 each rsu represents a contingent right to receive one ordinary share or cash in lieu thereof at the issuer's discretion.
WhaleWisdom Logo

Elevate your investments